18.7 C
New York
Saturday, June 3, 2023

Is Caribou Biosciences Inc. (NASDAQ: CRBU) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Caribou Biosciences Inc. (CRBU) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.07, or -1.62%, to $4.26. The Caribou Biosciences Inc. has recorded 17,061 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Caribou Biosciences to Participate in Upcoming Investor Conferences.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Caribou Biosciences Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $4.33 and fluctuated between $4.4300 as its day high and $4.1900 as its day low. The current market capitalization of Caribou Biosciences Inc. is $257.38M. A total of 0.5 million shares were traded on the day, compared to an average of 499.78K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CRBU has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 10,000 and the disposition of 0 shares. Over the last 12 months, there were 13 BUYs and 3 SELLs from insiders. Insiders purchased 199,464 shares during that period but sold 58,875.

In the most recent transaction, Rizvi Syed Ali-aamir sold 5,627 shares of CRBU for 6.31 per share on Jan 19. After the transaction, the Chief Medical Officer now owns 59,373 company shares. In a previous transaction on Oct 06, Fischesser Ryan sold 10,000 shares at 10.80 per share. CRBU shares that VP of Finance and Controller owns now total 110,366.

Among the insiders who sold shares, Kanner Steven disposed of 43,248 shares on Aug 25 at a per-share price of $11.22. This resulted in the Chief Scientific Officer holding 302,059 shares of CRBU after the transaction.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CRBU in the last 3 months, the mean price target is $28.86 with high estimates of $37.00 and low estimates of $19.00. In terms of 52-week highs and lows, CRBU has a high of $13.19 and a low of $4.05.

As of this writing, CRBU has an earnings estimate of $-0.49 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $-0.42 per share and a lower estimate of $-0.52. The company reported an EPS of $-0.44 in the last quarter, which was 8.30% higher than expectations of $-0.48.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CRBU’s latest balance sheet shows that the firm has $413.51M in Cash & Short Term Investments as of fiscal 2021. There were $1.58M in debt and $25.83M in liabilities at the time. Its Book Value Per Share was $4.93, while its Total Shareholder’s Equity was $387.82M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRBU is Overweight with a score of 4.86. A total of 7 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles